Law Commons^™

Ua12/2/1 Phase - Drugs On Campus, Wku Student Affairs

WKU Archives Records

Special magazine edition of the College Heights Herald:

• Grundy, Julie. Reality Check: We’re a Town That Has Drugs – Rebecca Maldonado, Student Health Services
• Bernardy, Patrick. Local Drug Use: A Slow But Steady Rise – WKU Police, Audrey Spies
• Quarles, Mitchell. Know the Downers: Jail, Fines, Probation
• Hutchins, Chris. I Did It Because It Was Fun . . . I Did Them to Escape – Drug Abuse
• Bernardy, Patrick. Marijuana No Worse than Alcohol
• Hieb, Dan. Drugs Steal Freedom; Don’t Create It

Anatomy Of A Regulatory Program: Comment On 'Strategic Regulators And The Choice Of Rulemaking Procedures', Jeffrey Lubbers

Articles in Law Reviews & Other Academic Journals

Besides being a very interesting, cogent, and even a tidy study, "Strategic Regulators" sheds some bright light on agency behavior and on the important issue of whether agency rulemaking may be "ossifying."

The study design employed by Hamilton and Schroeder is attractively simple. They started with all of the Environmental Protection Agency's ("EPA's") hazardous waste regulations under the Resource Conservation and Recovery Act ("RCRA") appearing in the Code of Federal Regulations ("CFR"), counting each decimal point CFR number as a separate rule. This yielded 697 rules. They then examined all EPA/RCRA guidance documents issued since the inception of the program …

Book Review: Aids In The World, 16 Hous. J. Int'l L. 709 (1994), Mark E. Wojcik

UIC Law Open Access Faculty Scholarship

No abstract provided.

Deterring Inefficient Pharmaceutical Litigation: An Economic Rationale For The Fda Regulatory Compliance Defense, W. Kip Viscusi

Vanderbilt Law School Faculty Publications

This Article examines the interaction between direct regulation of pharmaceuticals under the Federal Food Drug and Cosmetic Act (FDCA) and the indirect regulation of pharmaceuticals provided by common law tort incentives. The Article concludes that tort liability is generally inappropriate in cases where manufacturers have complied with the FDCA. The Article begins with a description of the FDCA's operation, and provides an overview of the Food and Drug Administration's (FDA) role in the drug approval process and drug labeling. This overview will demonstrate the need for centralized control over drug labeling. Moreover, we will provide an explanation of the costs …